NTLA FY 2015 Earnings — Intellia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

NTLAIntellia Therapeutics, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M

Gross Profit

-$5M-84.8% margin

Operating Income

-$13M-221.9% margin

Net Income

-$12M-205.1% margin

EPS (Diluted)

$-0.70

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$82M

Total Liabilities

$15M

Stockholders' Equity

$67M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$0	—
Gross Profit	-$5M	-$2M	-209.3%
Operating Income	-$13M	-$5M	-156.6%
Net Income	-$12M	-$14M	+13.4%